HGS BioScience Acquires Pharmgrade

January 13, 2026

Paine Schwartz Partners–backed HGS BioScience has acquired Pharmgrade, an Idaho-based developer of microbial consortium products, to strengthen its microbial capabilities and expand its integrated biologicals platform. The deal enhances HGS's R&D, formulation and manufacturing depth and helps scale Pharmgrade’s microbial technologies to retailers and growers across North America.

Buyers
HGS BioScience, Paine Schwartz Partners
Targets
Pharmgrade
Platforms
HGS BioScience
Industry
Agriculture
Location
Idaho, United States
Transaction Type
Addon

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.